missing translation for 'onlineSavingsMsg'
Learn More
Learn More
EGFR, p Tyr1092 Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody
Brand: Novus Biologicals NB100-81894-0.025ML
This item is not returnable.
View return policy
Description
EGFR Polyclonal specifically detects EGFR in Human, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.
Specifications
| EGFR (p Tyr1092) | |
| Polyclonal | |
| Unconjugated | |
| PBS (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, and 50% glycerol. with 0.02% Sodium Azide | |
| avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ERBB, ErbB1, ERBB1PIG61, HER1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1 | |
| Rabbit | |
| 175 kDa | |
| 0.025 mL | |
| Cancer, Cell Biology, Cell Cycle and Replication, Growth and Development, Hypoxia, Phospho Specific, Signal Transduction, Tumor Suppressors, Tyrosine Kinases | |
| 1956 | |
| Rat, Human, Mouse | |
| IgG |
| Immunohistochemistry, Immunohistochemistry (Paraffin), Western Blot | |
| 1.0 mg/mL | |
| Western Blot 1:500-1:1000, Immunohistochemistry 1:50-1:100, Immunohistochemistry-Paraffin 1:50-1:100 | |
| P00533 | |
| EGFR | |
| The antiserum was produced against synthesized phosphopeptide derived from human EGFR around the phosphorylation site of tyrosine1092 (P-E-YP-I-N). | |
| Affinity Purified | |
| RUO | |
| Primary | |
| EGFR (specific to Phospho-tyr1092) detects endogenous levels of EGFR only when phosphorylated at tyrosine 1092. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction